Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,778,581 | 4,778,581 | 0 | $134.99M | $165.24M | 56.95% | +$30.25M |
| Cytokinetics, Incorporated(CYTK) | 503,295 | 714,695 | +211,400 | $33.17M | $60.88M | 20.98% | +$27.71M |
| Eikon Therapeutics, Inc.(EIKN) | 1,943,682 | 1,943,682 | 0 | $20.56M | $25.37M | 8.74% | +$4.80M |
| Relay Therapeutics, Inc.(RLAY) | 1,000,000 | 1,250,000 | +250,000 | $9.95M | $23.39M | 8.06% | +$13.44M |
| Xenon Pharmaceuticals Inc.(XENE) | 160,000 | 160,000 | 0 | $9.30M | $9.66M | 3.33% | +$353.6K |
| Crinetics Pharmaceuticals, Inc. | 0 | 150,000 | +150,000 | $0 | $5.61M | 1.93% | +$5.61M |
| Alector, Inc. | 3,887,200 | 0 | -3,887,200 | $8.36M | $0 | — | -$8.36M |
| Lyell Immunopharma, Inc.(LYEL) | 800,399 | 0 | -800,399 | $16.06M | $0 | — | -$16.06M |
| Maze Therapeutics, Inc.(MAZE) | 156,901 | 0 | -156,901 | $4.68M | $0 | — | -$4.68M |